Tandem Diabetes Care Inc (TNDM):企業の製品パイプライン分析2018

◆英語タイトル:Tandem Diabetes Care Inc (TNDM) - Product Pipeline Analysis, 2018 Update
◆商品コード:DATA904C2884
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:32
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD1,500 ⇒換算¥222,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD2,250 ⇒換算¥333,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Tandem Diabetes Care Inc (Tandem) is a medical device company that designs, develops and manufactures diabetic care products. The company provides products such as t:slim X2 insulin pump, t:slim G4 insulin pump, t:flex insulin pump, t:simulator demo app, software and apps, t:connect application and tandem device updater, among others. It utilizes micro-delivery and color touchscreen technologies. Tandem also provides infusion set, which is a 90° flexible soft cannula. The company offers a wide range of accessories and supplies to help its clients to further customize their systems. It markets its products through its distribution network. Tandem is headquartered in San Diego, California, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Tandem Diabetes Care Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Tandem Diabetes Care Inc Company Overview 4
Tandem Diabetes Care Inc Company Snapshot 4
Tandem Diabetes Care Inc Pipeline Products and Ongoing Clinical Trials Overview 4
Tandem Diabetes Care Inc – Pipeline Analysis Overview 6
Tandem Diabetes Care Inc – Key Facts 6
Tandem Diabetes Care Inc – Major Products and Services 7
Tandem Diabetes Care Inc Pipeline Products by Development Stage 8
Tandem Diabetes Care Inc Ongoing Clinical Trials by Trial Status 10
Tandem Diabetes Care Inc Pipeline Products Overview 12
AutoSoft XC 12
AutoSoft XC Product Overview 12
Next Generation Gswim 13
Next Generation Gswim Product Overview 13
Next-Generation t:slim X2 Insulin Pump – Pediatric 14
Next-Generation t:slim X2 Insulin Pump – Pediatric Product Overview 14
t:slim X2 Insulin Pump 15
t:slim X2 Insulin Pump Product Overview 15
t:Slim X2 Pump With Dexcom G5 Mobile CGM Integration 16
t:Slim X2 Pump With Dexcom G5 Mobile CGM Integration Product Overview 16
t:slim X2 Pump With Dexcom G6 and HCL 17
t:slim X2 Pump With Dexcom G6 and HCL Product Overview 17
t:slim X2 Pump With Dexcom G6 and HCL Clinical Trial 18
t:sport 19
t:sport Product Overview 19
Tandem Diabetes Care Inc – Key Competitors 20
Tandem Diabetes Care Inc – Key Employees 21
Tandem Diabetes Care Inc – Locations And Subsidiaries 22
Head Office 22
Recent Developments 23
Tandem Diabetes Care Inc, Recent Developments 23
Jun 21, 2018: Tandem Diabetes Care Announces FDA Approval of t:slim X2 Insulin Pump with Basal-IQ Technology 23
Apr 30, 2018: Tandem Diabetes Care Receives CE Mark for t:slim X2 Insulin Pump 23
Apr 30, 2018: Tandem Diabetes Care Receives CE Mark for t:slim X2 Insulin Pump 23
Apr 30, 2018: Covalon to Showcase MediClear PreOp at AATS 2018 Annual Meeting 24
Apr 26, 2018: Tandem Diabetes Care Reports First Quarter 2018 Financial Results 24
Apr 23, 2018: Tandem Diabetes Care Announces Agreements for Distribution of Insulin Pump Products in Australia and New Zealand 25
Apr 10, 2018: Tandem Diabetes Care Announces Preliminary First Quarter 2018 Results 25
Apr 09, 2018: Tandem Diabetes Care and Movi SpA Announce Agreement for Distribution of Insulin Pump Products in Italy 26
Mar 01, 2018: Tandem Diabetes Care Announces 2017 Financial Results 26
Feb 20, 2018: Tandem Diabetes Care Applies for Health Canada Medical Device License 27
Appendix 29
Methodology 29
About GlobalData 32
Contact Us 32
Disclaimer 32

List of Tables
Tandem Diabetes Care Inc Pipeline Products and Ongoing Clinical Trials Overview 4
Tandem Diabetes Care Inc Pipeline Products by Equipment Type 5
Tandem Diabetes Care Inc Pipeline Products by Indication 5
Tandem Diabetes Care Inc Ongoing Clinical Trials by Trial Status 5
Tandem Diabetes Care Inc, Key Facts 6
Tandem Diabetes Care Inc, Major Products and Services 7
Tandem Diabetes Care Inc Number of Pipeline Products by Development Stage 8
Tandem Diabetes Care Inc Pipeline Products Summary by Development Stage 9
Tandem Diabetes Care Inc Ongoing Clinical Trials by Trial Status 10
Tandem Diabetes Care Inc Ongoing Clinical Trials Summary 11
AutoSoft XC - Product Status 12
AutoSoft XC - Product Description 12
Next Generation Gswim - Product Status 13
Next Generation Gswim - Product Description 13
Next-Generation t:slim X2 Insulin Pump - Pediatric - Product Status 14
Next-Generation t:slim X2 Insulin Pump - Pediatric - Product Description 14
t:slim X2 Insulin Pump - Product Status 15
t:slim X2 Insulin Pump - Product Description 15
t:Slim X2 Pump With Dexcom G5 Mobile CGM Integration - Product Status 16
t:Slim X2 Pump With Dexcom G5 Mobile CGM Integration - Product Description 16
t:slim X2 Pump With Dexcom G6 and HCL - Product Status 17
t:slim X2 Pump With Dexcom G6 and HCL - Product Description 17
t:slim X2 Pump With Dexcom G6 and HCL - A Pivotal Study of t:Slim X2 with Control-IQ Technology 18
t:sport - Product Status 19
t:sport - Product Description 19
Tandem Diabetes Care Inc, Key Employees 21
Glossary 31

List of Figures
Tandem Diabetes Care Inc Pipeline Products by Equipment Type 5
Tandem Diabetes Care Inc Pipeline Products by Development Stage 8
Tandem Diabetes Care Inc Ongoing Clinical Trials by Trial Status 10

★海外企業調査レポート[Tandem Diabetes Care Inc (TNDM):企業の製品パイプライン分析2018]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Korea Electric Power Corp (015760):電力:M&Aディール及び事業提携情報
    Summary Korea Electric Power Corp (KEPCO) is an integrated electric utility. It generates, transmits, and distributes electricity. The company produces electricity using nuclear, thermal, renewable, and other sources. Through power purchase agreements with independent power producers, KEPCO procures …
  • Cellect Biotechnology Ltd (APOP):医療機器:M&Aディール及び事業提携情報
    Summary Cellect Biotechnology Ltd (Cellect Biotechnology) formerly Cellect Biomed Ltd is a clinical stage biotechnology company which develops stem cell selection technologies for the production of stem cells based products in the field of regenerative medicine. The company’s technology platform is …
  • CPC Corp:企業の戦略的SWOT分析
    CPC Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Thi …
  • Kenya Power and Lighting Co Ltd (KPLA):企業の財務・戦略的SWOT分析
    Kenya Power and Lighting Co Ltd (KPLA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Prysmian SpA (PRY):電力:M&Aディール及び事業提携情報
    Summary Prysmian SpA (Prysmian) is a provider of cables and systems. It designs, develops, manufactures, supplies, and installs cables for a wide range of applications. The company produces high- and medium voltage cable systems; high and extra high voltage cables; optical fiber, optical cables, opt …
  • Pets at Home Group Plc.:企業の戦略・SWOT・財務分析
    Pets at Home Group Plc. - Strategy, SWOT and Corporate Finance Report Summary Pets at Home Group Plc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Israel Chemicals Ltd.:企業の戦略・SWOT・財務分析
    Israel Chemicals Ltd. - Strategy, SWOT and Corporate Finance Report Summary Israel Chemicals Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • MGB Biopharma Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary MGB Biopharma Ltd (MGB Biopharma) is a a biopharmaceutical company which develops novel class of anti-infectives using Minor Groove Binder (MGBs) compounds. Its lead drug candidate MGB-BP-3 in the field of antibacterial resistance is active against may Gram-positive bacteria. MGB Biopharma a …
  • Merus Labs International Inc (MSL):企業の財務・戦略的SWOT分析
    Summary Merus Labs International Inc (Merus Labs International), formerly Merus Labs Inc, a subsidiary of Norgine BV, is a pharmaceutical company that provides medicinal products. The company offers products in the therapeutic areas of cardiovascular, oncology support, women's health, urology, and i …
  • Odonate Therapeutics Inc (ODT):製薬・医療:M&Aディール及び事業提携情報
    Summary Odonate Therapeutics Inc (Odonate), formerly Odonate Therapeutics LLC, is a pharmaceutical company that develops medicines for the treatment of cancer. The company provides product candidate, tesetaxel which is a novel orally administered taxane used for the treatment of advanced and metasta …
  • Asarina Pharma AB:製薬・医療:M&Aディール及び事業提携情報
    Summary Asarina Pharma AB (Asarina Pharma), formerly Umecrine Mood AB, a subsidiary of Umecrine AB, is a sepranolone product developer. The company offers discovery, development and commercialization of novel treatments for women suffering from premenstrual dysphoric disorder and other menstrual cyc …
  • Maruho Co Ltd:企業の戦略的SWOT分析
    Maruho Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Chembio Diagnostic Inc (CEMI):企業の財務・戦略的SWOT分析
    Chembio Diagnostic Inc (CEMI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • QEP Resources, Inc.:企業の戦略・SWOT・財務情報
    QEP Resources, Inc. - Strategy, SWOT and Corporate Finance Report Summary QEP Resources, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • AviChina Industry & Technology Co., Ltd.:企業の戦略・SWOT・財務情報
    AviChina Industry & Technology Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary AviChina Industry & Technology Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Electric Power Development Co Ltd (9513):電力:M&Aディール及び事業提携情報
    Summary Electric Power Development Co., Ltd. (J-Power) is a wholesale electric utility that supplies hydroelectric and thermal power. It owns and operates a network of hydroelectric, thermal, wind and geothermal power plants. The group provides electricity and transmission services to major electric …
  • Harvard Bioscience Inc (HBIO):医療機器:M&Aディール及び事業提携情報
    Summary Harvard Bioscience Inc (Harvard Bioscience) develops, manufactures and markets scientific instruments systems and lab consumables. The company’s product portfolio encompasses physiology, cell, molecular instruments products; electrophysiology products; and laboratory products and supplies. I …
  • Shanghai Jin Jiang International Hotels (Group) Co Ltd:戦略・SWOT・企業財務分析
    Shanghai Jin Jiang International Hotels (Group) Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Shanghai Jin Jiang International Hotels (Group) Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company' …
  • Sichuan Kelun Pharmaceutical Co Ltd (002422)-製薬・医療分野:企業M&A・提携分析
    Summary Sichuan Kelun Pharmaceutical Co Ltd (Kelun) is a pharmaceutical company that manufactures and distributes IV Solutions. The company’s products include mannitol injection, glucose injection, sodium chloride injection, glucose and sodium chloride injection, ringer’s injection, lactated ringer’ …
  • Bilim Pharmaceuticals:企業の戦略的SWOT分析
    Bilim Pharmaceuticals - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆